Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-11-07 00:00:00 ET · period of report 2022-11-03 · accession 0000899243-22-035326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-07 | 2022-11-03 | DNA | DEKKERS MARIJN E | Dir | S - Sale | $2.56 | -171.5K | 2.02M | -8% | -$438.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-03 | S | D | 171,455 | $2.56 | 2,021,132 | D | — | — | (F1) Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units. |